A new synthetic route of 83435-58-9

Compounds in my other articles are similar to this one(Boc-D-Prolinol)HPLC of Formula: 83435-58-9, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Most of the natural products isolated at present are heterocyclic compounds, so heterocyclic compounds occupy an important position in the research of organic chemistry. A compound: 83435-58-9, is researched, SMILESS is O=C(N1[C@@H](CO)CCC1)OC(C)(C)C, Molecular C10H19NO3Journal, Article, Journal of Medicinal Chemistry called Discovery of 4-[(2S)-2-{[4-(4-Chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic Acid (DG-051) as a Novel Leukotriene A4 Hydrolase Inhibitor of Leukotriene B4 Biosynthesis, Author is Sandanayaka, Vincent; Mamat, Bjorn; Mishra, Rama K.; Winger, Jennifer; Krohn, Michael; Zhou, Li-Ming; Keyvan, Monica; Enache, Livia; Sullins, David; Onua, Emmanuel; Zhang, Jun; Halldorsdottir, Gudrun; Sigthorsdottir, Heida; Thorlaksdottir, Audur; Sigthorsson, Gudmundur; Thorsteinnsdottir, Margret; Davies, Douglas R.; Stewart, Lance J.; Zembower, David E.; Andresson, Thorkell; Kiselyov, Alex S.; Singh, Jasbir; Gurney, Mark E., the main research direction is pyrrolidinylbutanoate preparation leukotriene hydrolase inhibitor SAR.HPLC of Formula: 83435-58-9.

Both inhouse human genetic and literature data have converged on the identification of leukotriene 4 hydrolase (LTA4H) as a key target for the treatment of cardiovascular disease. We combined fragment-based crystallog. screening with an iterative medicinal chem. effort to optimize inhibitors of LTA4H. Ligand efficiency was followed throughout our structure-activity studies. As applied within the context of LTA4H inhibitor design, the chem. team was able to design a potent compound 20 (DG-051, I) (Kd = 26 nM) with high aqueous solubility (>30 mg/mL) and high oral bioavailability (>80% across species) that is currently undergoing clin. evaluation for the treatment of myocardial infarction and stroke. The structural biol.-chem. interaction described in this paper provides a sound alternative to conventional screening techniques. This is the first example of a gene-to-clinic paradigm enabled by a fragment-based drug discovery effort.

Compounds in my other articles are similar to this one(Boc-D-Prolinol)HPLC of Formula: 83435-58-9, you can compare them to see their pros and cons in some ways,such as convenient, effective and so on.

Reference:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica